Identification | Back Directory | [Name]
5-(4-broMo-2-chlorophenylaMino)-4-fluoro-1-Methyl-1H-benzo[d]iMidazole-6-carboxylic acid | [CAS]
606144-04-1 | [Synonyms]
1H-Benzimidazole-6-carboxylic acid, 5-[(4-bromo-2-chlorophen... 6-(4-bromo-2-chloroanilino)-7-fluoro-3-methylbenzimidazole-5-carboxylic acid 6-(4-Bromo-2-chlorophenylamino)-7-fluoro-3-methyl-benzimidazole-5-carboxylic acid 1H-BenziMidazole-6-carboxylic acid,5-[(4-broMo-2-chlorophenyl)aMino]-4-fluoro-1-Methyl- 5-(4-broMo-2-chlorophenylaMino)-4-fluoro-1-Methyl-1H-benzo[d]iMidazole-6-carboxylic acid 6-(4-broMo-2-chlorophenylaMino)-7-fluoro-3-Methyl-3H-benzo[d]iMidazole-5-carboxylic acid | [Molecular Formula]
C15H10BrClFN3O2 | [MDL Number]
MFCD09953722 | [MOL File]
606144-04-1.mol | [Molecular Weight]
398.61 |
Hazard Information | Back Directory | [Uses]
5-((4-Bromo-2-chlorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylic Acid is a useful intermediate for organic synthesis processes. it is used in the preparation of selumetinib and it’s related impurities. | [Synthesis]
General procedure for the synthesis of 5-((4-bromo-2-chlorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylic acid methyl ester: 5-((4-bromo-2-chlorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylic acid methyl ester (2 g, from Example 4) was dissolved in tetrahydrofuran (20 mL), deionized water (10 mL) was added. and [d]imidazole-6-carboxylic acid methyl ester (2 g, from Example 4) was dissolved in tetrahydrofuran (20 mL), deionized water (10 mL) was added, and the reaction temperature was maintained at 25°C to 30°C. A solution of sodium hydroxide (0.74 g) in deionized water (4 mL) was added slowly and dropwise to the reaction mixture over 10 minutes at the same temperature. The reaction mixture was stirred continuously for 3 hours, maintaining the temperature at 25°C to 30°C. Upon completion of the reaction (monitored by TLC), tetrahydrofuran was removed by distillation under reduced pressure at 40 °C to 45 °C and deionized water (20 mL) was added. The aqueous phase was extracted with dichloromethane (2 x 20 mL). The aqueous phase was cooled to 5 °C to 10 °C, the pH was adjusted to 1.3 with 50% aqueous hydrochloric acid, and stirring was continued at 5 °C to 10 °C for 30 min. The precipitated solid was collected by filtration and washed with deionized water (2 x 20 mL). The wet solid was dried under reduced pressure at 35 °C to 40 °C for 14 h to afford the target product 5-((4-bromo-2-chlorophenyl)amino)-4-fluoro-1 -methyl-1H-benzo[d]imidazole-6-carboxylic acid in 88.5% yield.1H NMR (d6-DMSO, 400 MHz): δ 3.92 (s, 3H), 6.48-6.51 (m, 1H), 7.30-7.32 (m, 1H), 7.64-7.65 (d, 1H), 8.10 (s, 1H), 8.44 (s, 1H), 8.52 (s, 1H). Mass (m/z): 400.1 [M+2]. | [References]
[1] Patent: WO2018/65924, 2018, A1. Location in patent: Page/Page column 10; 11 [2] Patent: US2004/116710, 2004, A1. Location in patent: Page 22 [3] Patent: WO2007/76245, 2007, A2. Location in patent: Page/Page column 20-21 [4] Patent: US2003/232869, 2003, A1. Location in patent: Page 10; 22; 23 |
|
Company Name: |
ChemCell Biomedicine Co.,Ltd.
|
Tel: |
020-13556033878 2965585218 13556033878 |
Website: |
www.chemicalbook.com/ShowSupplierProductsList15061/0_EN.htm |
Company Name: |
Heterochem
|
Tel: |
027-88041443 13072715837 |
Website: |
www.hetero-chem.com |
Company Name: |
Tcichem, Inc.
|
Tel: |
13918644899 |
Website: |
www.chemicalbook.com/ShowSupplierProductsList19113/0_EN.htm |
|